11 Recruiting Crohn's Disease Clinical Trials in Alabama
Explore active crohn's disease research studies enrolling across Alabama. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Crohn's Disease Studies in Alabama
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
📍 Univ Alabama, Birmingham CCC /ID# 146060 — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
📍 University of Alabama Liver Center — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
📍 Digestive Health Specialists — Dothan, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
📍 Clinical Research Facility — Mobile, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
📍 Digestive Health Specialists of the Southeast — Dothan, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
📍 East View Medical Research, LLC /ID# 171132 — Mobile, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
📍 Digestive Health Specialists /ID# 266216 — Dothan, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
📍 Digestive Health Specialists /ID# 280827 — Dothan, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
📍 Digestive Health Specialists — Dothan, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase4 💊 Investigational Drug / Biologic
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
📍 Digestive Health Specialsits — Dothan, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
📍 Digestive Health Specialists ( Site 5064) — Dothan, Alabama
View Study & Checklist ➔